UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Enrolling by invitation
Unique ID issued by UMIN UMIN000002982
Receipt No. R000003618
Scientific Title Effects of TS-1 and heparin-based chemoradiation combined with MMC, CDDP, and GEM on the locally advanced pancreatic cancer.
Date of disclosure of the study information 2010/01/20
Last modified on 2015/04/08

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Effects of TS-1 and heparin-based chemoradiation combined with MMC, CDDP, and GEM on the locally advanced pancreatic cancer.
Acronym Effects of TS-1 and heparin-based chemoradiation on the locally advanced pancreatic cancer.
Scientific Title Effects of TS-1 and heparin-based chemoradiation combined with MMC, CDDP, and GEM on the locally advanced pancreatic cancer.
Scientific Title:Acronym Effects of TS-1 and heparin-based chemoradiation on the locally advanced pancreatic cancer.
Region
Japan

Condition
Condition locally advanced pancreatic cancer
Classification by specialty
Hepato-biliary-pancreatic surgery
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 To investigate the effects of TS-1 and heparin-based chemoradiation combined with MMC, CDDP, and GEM on the locally advanced pancreatic cancer
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Overall survival
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control No treatment
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 with TS-1 and heparin-based chemoradiation combined with MMC, CDDP
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
85 years-old >=
Gender Male and Female
Key inclusion criteria locally advanced pancreatic cancer
Key exclusion criteria cases with metastasis
Target sample size 20

Research contact person
Name of lead principal investigator
1st name
Middle name
Last name Minoru Kitago
Organization Department of Surgery, Keio University School of Medicine
Division name Department of Surgery
Zip code
Address Shinanomachi 35, shinjuku-ku
TEL 03-3353-1211(ext62529)
Email contact@keio-hpbts.jp

Public contact
Name of contact person
1st name
Middle name
Last name Minoru Kitago
Organization Department of Surgery, Keio University School of Medicine
Division name Department of Surgery
Zip code
Address Shinanomachi 35, shinjuku-ku
TEL 03-3353-1211(ext62529)
Homepage URL
Email contact@keio-hpbts.jp

Sponsor
Institute Keio University School of Medicine
Institute
Department

Funding Source
Organization non
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 慶應義塾大学病院

Other administrative information
Date of disclosure of the study information
2010 Year 01 Month 20 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Enrolling by invitation
Date of protocol fixation
2009 Year 10 Month 14 Day
Date of IRB
Anticipated trial start date
2010 Year 01 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2010 Year 01 Month 06 Day
Last modified on
2015 Year 04 Month 08 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000003618

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.